InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,842.47
(
0.47%
)
US TECH 100
19,624.00
(
-0.05%
)
Dow Jones
43,077.70
(
0.79%
)
Brent Oil
74.22
(
-0.34%
)
Bitcoin
67,551.71
(
0.81%
)
Post# of 253384
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

edcoolidge

Send PM Follow Ignore
Followers 1
Posts 417
Boards Moderated 0
Alias Born 07/17/2023

edcoolidge

Re: jmkobers post# 248230

Thursday, 07/27/2023 12:57:02 PM

Thursday, July 27, 2023 12:57:02 PM

Post# of 253384
My counterpoint would be that clinical data is nice but as awareness of how superior Daxxify is to Botox continues to permeate social media, potential buyers may emerge who had not previously considered Revance.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up